摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

L-亮氨酸烯丙酯对甲苯硫酸盐 | 88224-03-7

中文名称
L-亮氨酸烯丙酯对甲苯硫酸盐
中文别名
L-亮氨酸烯丙酯4-甲苯磺酸盐
英文名称
L-leucine allyl ester hydro-p-toluenesulfonate
英文别名
L-leucine allyl ester hydro-p-tosylate;leucine allylester hydrotosylate;L-leucine allyl ester tosylate;H-Leu-OAll*TsOH;HLeuOAll*p-TsOH;H-Leu-OAll tosylate;(S)-Allyl 2-amino-4-methylpentanoate 4-methylbenzenesulfonate;4-methylbenzenesulfonic acid;prop-2-enyl (2S)-2-amino-4-methylpentanoate
L-亮氨酸烯丙酯对甲苯硫酸盐化学式
CAS
88224-03-7
化学式
C7H8O3S*C9H17NO2
mdl
MFCD00043312
分子量
343.444
InChiKey
VIDHIGJZWRNZDG-QRPNPIFTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    溶于氯仿、二氯甲烷、乙酸乙酯、DMSO、丙酮等。

计算性质

  • 辛醇/水分配系数(LogP):
    1.55
  • 重原子数:
    23
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.437
  • 拓扑面积:
    115
  • 氢给体数:
    2
  • 氢受体数:
    6

安全信息

  • WGK Germany:
    3

SDS

SDS:47801e36493b4336b2f6b6fb215f53be
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: L-Leucine allyl ester 4-toluenesulfonate salt
Synonyms: H-Leu-OAll Tos-OH

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: L-Leucine allyl ester 4-toluenesulfonate salt
CAS number: 88224-03-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H17NO2.C7H8O3S
Molecular weight: 343.4

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Turn Formation Initiated by a Bissulfoximine Motif:  Synthesis and Structural Investigation
    摘要:
    [GRAPHICS]Bissulfoximines containing heterochiral SulfCO-SulfCO units may be used as molecular templates, which induce U-shaped conformations in peptidelike structures. The synthesis of such molecules has been investigated, and the structural requirements of this new turn motif have been identified.
    DOI:
    10.1021/ol017188r
  • 作为产物:
    描述:
    L-亮氨酸对甲苯磺酸烯丙醇 为溶剂, 以91%的产率得到L-亮氨酸烯丙酯对甲苯硫酸盐
    参考文献:
    名称:
    Waldmann, Herbert; Kunz, Horst, Liebigs Annalen der Chemie, 1983, # 10, p. 1712 - 1725
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • 2,2′-dithiobisbenzamides derived from α-, β- and γ-amino acids possessing anti-HIV activities: synthesis and structure–activity relationship
    作者:J.V.N Vara Prasad、Joseph A Loo、Frederick E Boyer、Michael A Stier、Rocco D Gogliotti、William J Turner、Patricia J Harvey、Melissa R Kramer、David P Mack、Jefferey D Scholten、Stephen J Gracheck、John M Domagala
    DOI:10.1016/s0968-0896(98)00118-7
    日期:1998.10
    2'-dithiobisbenzamides derived from alpha-, beta- and gamma-amino acids. Electrospray ionization mass spectrometry was used to study the zinc-ejection activity of these compounds. Among the alpha-amino acid derived 2,2'-dithiobisbenzamides, analogues containing alkyl side chains were found to be antivirally active with good therapeutic indices. 2,2'-Dithiobisbenzamides, derived from beta- and gamma-amino
    含有高度保守的逆转录病毒锌指的核衣壳蛋白(NCp7)在人类免疫缺陷病毒(HIV)生命周期的早期和晚期都是必不可少的,并且是AIDS治疗的新目标。HIV-1 NCp7是基本的55个氨基酸氨基酸蛋白,在两侧各含两个C(X)2C(X)4H(X)4C基序锌指。先前已报道2,2'-二硫代双苯甲酰胺从这些NCp7锌指中释放锌,并抑制HIV复制。具体而言,衍生自简单氨基酸的2,2'-二硫代双苯甲酰胺显示出良好的抗病毒活性。苯并异噻唑酮3(2的环状衍生物)被选为临床试验中的艾滋病治疗剂。本文中我们报告了2,2'的合成和抗病毒活性,包括治疗指数 衍生自α-,β-和γ-氨基酸的β-二硫代双苯甲酰胺。电喷雾电离质谱法用于研究这些化合物的锌喷射活性。在α-氨基酸衍生的2,2'-二硫代双苯甲酰胺中,发现含有烷基侧链的类似物具有良好的治疗指数,具有抗病毒活性。发现衍生自β-和γ-氨基酸的2,2'-二硫代双苯甲酰胺比α
  • Sequentially Photocleavable Protecting Groups in Solid-Phase Synthesis
    作者:Martin Kessler、Ralf Glatthar、Bernd Giese、Christian G. Bochet
    DOI:10.1021/ol027454g
    日期:2003.4.1
    [reaction: see text] A sequential solid-phase peptide synthesis was developed using both photolabile linker and protecting groups. The chromatic sequential lability between a tert-butyl ketone-derived linker (sensitive to irradiation at 305 nm) and a nitroveratryloxycarbonyl (NVOC) group (sensitive at 360 nm) was exploited to prepare Leu-Enkephalin in a 55% overall yield. This new strategy allows the
    [反应:见正文]使用光不稳定的连接基和保护基团开发了顺序的固相肽合成方法。利用叔丁基酮衍生的连接基(对305 nm的辐射敏感)和硝基过碳酰氧羰基(NVOC)基团(对360 nm敏感)之间的色序不稳定性来制备亮氨酸-脑啡肽,总产率为55%。通过避免使用常见的脱保护试剂(例如三氟乙酸或哌啶),该新策略允许在基本中性的介质中制备肽。
  • Convergent Synthesis of <i>N</i>-Linked Glycopeptides on a Solid Support
    作者:J. Y. Roberge、X. Beebe、S. J. Danishefsky
    DOI:10.1021/ja9740071
    日期:1998.4.1
    Oligosaccharides and glycopeptides are of considerable importance in molecular biology and pharmacology. However, their synthesis is complicated by the large number of different linking sites between each saccharide unit, the need for stereochemical control, the chemical sensitivity of the glycopeptide bonds, and the need to harmonize diverse protecting groups. Here, an efficient solid-phase synthesis of three
    寡糖和糖肽在分子生物学和药理学中具有相当重要的意义。然而,由于每个糖单元之间有大量不同的连接位点、需要立体化学控制、糖肽键的化学敏感性以及协调不同保护基团的需要,它们的合成变得复杂。在这里,提出了一种基于糖组装的三种 N 连接糖肽的有效固相合成。肽域可以扩展,而整体保持与聚合物结合。这里合成的糖肽是迄今为止通过溶液或固相合成获得的最大的 N 连接糖肽之一。
  • The 2-(Triphenylsilyl)ethoxycarbonyl-(“Tpseoc”-) Group: A New Silicon-Based, Fluoride Cleavable Oxycarbonyl Protecting Group Highly Orthogonal to the Boc-, Fmoc- and Cbz-Groups
    作者:Martin Golkowski、Thomas Ziegler
    DOI:10.3390/molecules16064695
    日期:——
    Starting from 2-(triphenylsilyl)ethanol a new oxycarbonyl protecting group cleavable by fluoride ion induced Peterson-elimination has been developed. Known 2-(triphenylsilyl)ethanol has been prepared from commercially available triphenylvinyl-silane by a hydroboration-oxidation sequence using the sterically hindered borane reagent 9-BBN. The silyl alcohol was subsequently transformed into its chloroformate
    从 2-(三苯基甲硅烷基)乙醇开始,开发了一种新的氧羰基保护基团,该基团可通过氟离子诱导的彼得森消除来裂解。已知的 2-(三苯基甲硅烷基)乙醇是通过使用空间位阻硼烷试剂 9-BBN 的硼氢化-氧化序列从市售的三苯基乙烯基硅烷制备的。随后将甲硅烷醇转化为其氯甲酸酯、咪唑基羧酸酯和对硝基苯基碳酸酯,并用于形成氨基甲酸酯和碳酸酯的标准方案。事实证明,Tpseoc 基团对用于去除叔丁酯和 t-Boc 基团的酸性条件具有很强的抵抗力。它还经受住了催化氢化、用吗啉、甲基肼和 Pd-试剂/烯丙基-清除剂组合的处理,以及裂解 Cbz-、Fmoc-、邻苯二甲酰亚胺和 Alloc 基团。Tpseoc-基团在 0°C 或室温下用 TBAF/CsF 处理后裂解,裂解时间从 <10 分钟起。到 24 小时。其正交性、易于裂解和紫外检测能力使 Tpseoc-基团成为其他广泛使用的硅基胺保护基团(如 Teoc-和 SES-基团)的有前途的替代品。
  • Total Synthesis of Lysobactin
    作者:Aikomari Guzman-Martinez、Ryan Lamer、Michael S. VanNieuwenhze
    DOI:10.1021/ja067648h
    日期:2007.5.1
    needed. Lysobactin, a depsipeptide antibiotic has displayed very strong antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) as well as vancomycin-resistant enterococci (VRE) with minimum inhibitory concentrations (MICs) ranging from 0.39 to 0.78 μg/mL. The MIC values against VRE were more than 50-fold lower than those reported for vancomycin itself. Lysobactin was found
    抗生素耐药性已成为一个重要的公共卫生问题。迫切需要属于新结构类别并通过新机制显示其生物活性的抗生素。溶菌素是一种缩肽类抗生素,对耐甲氧西林金黄色葡萄球菌 (MRSA) 和耐万古霉素肠球菌 (VRE) 显示出非常强的抗菌活性,最低抑菌浓度 (MIC) 为 0.39 至 0.78 μg/mL。针对 VRE 的 MIC 值比针对万古霉素本身报道的值低 50 倍以上。发现溶菌素抑制新生肽聚糖的形成;然而,在万古霉素利用的细胞壁前体上的结合域 N-酰基-1-Lys-d-Ala-d-Ala 存在的情况下,这种活性不会被拮抗。因此,溶菌素是治疗由耐药病原体引起的细菌感染的有前途的药物。我们描述了一种依赖于高效大环化的溶菌素聚合合成...
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物